PURPOSE: The aim of this study was to assess the effectiveness of Manuka honey ointment and dressings in the conservative management of exomphalos major (EM). METHODS: A retrospective review of five patients with EM who underwent non-operative management with Manuka honey ointments and dressings was carried out to assess the time to complete epithelialisation, time to full feeds, hospital stay, adverse effects, complications and outcome. RESULTS: The skin epithelialisation over the EM sac was achieved in a median of 63 days (48-119). The median time to full enteral feed was 13 days (3-29). The median hospital stay was 66 days (21-121). No adverse effects were noted related to Manuka honey. Three patients had pulmonary hypoplasia requiring prolonged hospitalization; one of those died with respiratory complications at home after achieving complete epithelialisation. The follow-up was a median 16 months (6-22). Two patients did not require repair of the ventral hernia. One patient had ventral hernia repair at 16 months with excellent cosmesis. The remaining patient is awaiting repair. CONCLUSION: This is the first description of the use of medicated Manuka honey ointment and impregnated dressings in the conservative management of EM. This treatment is safe, efficacious and promotes wound healing with favorable outcome.
PURPOSE: The aim of this study was to assess the effectiveness of Manuka honey ointment and dressings in the conservative management of exomphalos major (EM). METHODS: A retrospective review of five patients with EM who underwent non-operative management with Manuka honey ointments and dressings was carried out to assess the time to complete epithelialisation, time to full feeds, hospital stay, adverse effects, complications and outcome. RESULTS: The skin epithelialisation over the EM sac was achieved in a median of 63 days (48-119). The median time to full enteral feed was 13 days (3-29). The median hospital stay was 66 days (21-121). No adverse effects were noted related to Manuka honey. Three patients had pulmonary hypoplasia requiring prolonged hospitalization; one of those died with respiratory complications at home after achieving complete epithelialisation. The follow-up was a median 16 months (6-22). Two patients did not require repair of the ventral hernia. One patient had ventral hernia repair at 16 months with excellent cosmesis. The remaining patient is awaiting repair. CONCLUSION: This is the first description of the use of medicated Manuka honey ointment and impregnated dressings in the conservative management of EM. This treatment is safe, efficacious and promotes wound healing with favorable outcome.
Authors: Steven L Lee; Todd D Beyer; Stephen S Kim; John H T Waldhausen; Patrick J Healey; Robert S Sawin; Daniel J Ledbetter Journal: J Pediatr Surg Date: 2006-11 Impact factor: 2.545
Authors: L Bauer; A Kohlich; R Hirschwehr; U Siemann; H Ebner; O Scheiner; D Kraft; C Ebner Journal: J Allergy Clin Immunol Date: 1996-01 Impact factor: 10.793
Authors: Enrico Danzer; Holly L Hedrick; Natalie E Rintoul; Jennifer Siegle; N Scott Adzick; Howard B Panitch Journal: J Pediatr Surg Date: 2012-10 Impact factor: 2.545
Authors: Éile Butler; Rut F Oien; Christina Lindholm; Tobias C Olofsson; Bo Nilson; Alejandra Vásquez Journal: Int Wound J Date: 2014-09-08 Impact factor: 3.315